Get Real – no COVID-19 drug or vaccine in the short term

Vitamin C and Immuno-Oncology

A Prospective Alzheimers Trial Reports Results

The Higher States of Bromine

Another New Form of Carbon – It’s a Weird One

Copernicium Is a Strange Element Indeed

Quietly another drug candidate disappears

We Have the Touch

Sand won't save you this time

Magnetic stir bars can cause phantom results during organic and catalytic reactions as a consequence of microscale damage and contamination.

We Have Given People Amyloid Disease

Tumor-Specific Antigens from Way Out There

Real Progress in Parkinson’s

Lab-Made Whiskey, Lab-Made Wine

"Astonishing" breakthrough in structure determination of small-molecules last night

Thiel-funded drug Rova-T's failure shows why “right to try” is bad

Science Reform in China

Things I Won’t Work With: Dimethylcadmium (2013)

A computer program has been used to autonomously design synthetic pathways for eight commercially and medicinally relevant molecules that previously suffered from troublesome syntheses.

Calcium phosphate nanoparticles inhaled from air pollution localize to the heart

Expensive Shams Are the Way to Go, Apparently: The nocebo effect mirrors the placebo effect, complicating drug trials.

Allergan Pulls a Fast One: Patents Transferred to Indian Tribe

What do you get if you publish a paper in a highly-ranked journal?

The First Deuterated Drug Arrives

What This Here Compound Needs Is Some Hydrogen Peroxide

Things I Won’t Work With: Peroxide Peroxides (2014)

Nanoparticles don't really improve delivery to tumors at all, only 0.7% of systemic nanoparticle dose actually reaches a tumor, the 'EPR effect' is a leap, and there is an enormous problem of nanoparticle uptake by macrophages according to a new Nature Materials review.

CETP Finally Heads to the Trash Heap?

From the Far Corner of the Basement

Things I Won’t Work With: Dioxygen Difluoride

More →